The Ottawa Hospital, Civic Campus
Ottawa, Ontario, K1Y 4E9, Canada
NCT Number: NCT03875846
This study aims to determine whether intraoperative physiologic measurements of blood flow to the leg during endovascular treatment of Peripheral Arterial Disease (PAD) can predict future clinical outcomes.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ottawa, Ontario, K1Y 4E9, Canada
Lower extremity peripheral arterial disease (PAD) caused by atherosclerosis can cause cause leg pain, gangrene, and limb loss. PAD is a result of poor blood flow to the extremity, and the emerging most common initial method of interventional treatment is endovascular therapy, for example angioplasty or stenting. The poor blood flow to the extremity can be inferred by the hemodynamic pressure of blood in the leg. These toe or ankle pressure measurements are typically performed before surgery to diagnose PAD, and after surgery as surveillance.
However, endovascular treatment has a high failure rate often exceeding 20% within a year. There is evidence that physiologic measurements prior to treatment and after treatment are closely related to clinical outcomes. This study introduces these physiologic measurements to the operating room, to determine if physiologic improvement can be detected instantaneously during endovascular revascularization. Patients will be followed for a year following surgery to detect hemodynamic and clinical outcomes. The rationale of these intraoperative measurements would be to potentially guide future surgery, by providing real-time hemodynamic feedback to the operator.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Secondary analyses will examine the Ankle-Brachial Index, and the absolute limb pressures. In addition, the changes in flow rate of contrast before- and after- intervention will be examined as an indicator of perfusion.
Other names: Toe Brachial Index, Ankle Brachial Index, Absolute Toe Pressure, Absolute Ankle Pressure
A secondary analysis will examine the rate of contrast flow during pre-intervention and post-intervention angiograms, and correlate these findings with hemodynamic measurements recorded during surgery.
Other names: Time to Peak Opacification, Rate of Contrast Opacification, Wash-In Rate, Wash-Out Rate
Time frame: 1 Year
Composite outcome of major amputation above the ankle, major re-intervention in the form of catheter-directed thrombolysis, open bypass or thrombectomy.
Time frame: 1 Year
Any ipsilateral leg amputation performed above the joint of the ankle.
Time frame: 1 Year
Any ipsilateral leg amputation performed distal to the joint of the ankle.
Time frame: 1 Year
Endovascular, Open, Thrombectomy, Thrombolysis.
Time frame: 1 Year
Primary: Absence of target vessel occlusion or restenosis >50% Primary Assisted: Patency requiring assistance of subsequent procedure to maintain patency of target vessel Secondary: Patency requiring assistance of subsequent procedure to restore patency of target vessel
Time frame: 1 Year
Maximal documented categorical state following index revascularization
Time frame: 1 - 3 Months
Correlation between intraoperative completion and immediate post-operative measurements, with longer-term surveillance measurements
Time frame: 1 Year
As captured by the hospital's Electronic Health Record
Time frame: 1 Year
Survival free of major amputation.
Mark Rockley
Other
Acronym: INSTANT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07394829
Cardiovascular Diseases, Peripheral Vascular Diseases
Ağrı, Merkez, Turkey (Türkiye)
View Trial DetailsNCT03404180
Arterial Occlusive Diseases, Arteriosclerosis
Gainesville, Florida, United States
View Trial DetailsNCT05459818
Cardiovascular Diseases, Peripheral Vascular Diseases
Arnhem, Netherlands
View Trial DetailsNCT04440839
Arterial Occlusive Diseases, Arteriosclerosis
Sacramento, California, United States
View Trial Details